High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer
Authors
Keywords
-
Journal
npj Breast Cancer
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-23
DOI
10.1038/s41523-021-00333-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overcoming Endocrine Resistance in Breast Cancer
- (2020) Ariella B. Hanker et al. CANCER CELL
- Statin use and breast cancer survival – a Swedish nationwide study
- (2019) Signe Borgquist et al. BMC CANCER
- Intratumoral sterol-27-hydroxylase (CYP27A1) expression in relation to cholesterol synthesis and vitamin D signaling and its association with lethal prostate cancer
- (2019) Nabeela A Khan et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Host CYP27A1 expression is essential for ovarian cancer progression
- (2019) Sisi He et al. ENDOCRINE-RELATED CANCER
- Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness
- (2019) Giovanna Revilla et al. Scientific Reports
- Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial
- (2019) Hyun-Ah Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer
- (2018) Erik R. Nelson MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer
- (2017) Siker Kimbung et al. ENDOCRINE-RELATED CANCER
- Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study
- (2017) Signe Borgquist et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells
- (2017) Amy E. Baek et al. Nature Communications
- Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
- (2015) Prudence A. Francis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
- (2014) Olivia Pagani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statin Use and Breast Cancer Survival: A Nationwide Cohort Study from Finland
- (2014) Teemu J. Murtola et al. PLoS One
- Cholesterol and breast cancer pathophysiology
- (2014) Erik R. Nelson et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial
- (2013) M. Klintman et al. ANNALS OF ONCOLOGY
- 27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
- (2013) E. R. Nelson et al. SCIENCE
- 27-Hydroxycholesterol Promotes Cell-Autonomous, ER-Positive Breast Cancer Growth
- (2013) Qian Wu et al. Cell Reports
- A comprehensive method for extraction and quantitative analysis of sterols and secosteroids from human plasma
- (2012) Jeffrey G. McDonald et al. JOURNAL OF LIPID RESEARCH
- RNAscope
- (2011) Fay Wang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study
- (2011) T. P. Ahern et al. JNCI-Journal of the National Cancer Institute
- The oxysterol receptor LXR inhibits proliferation of human breast cancer cells
- (2009) Lise-Lotte Vedin et al. CARCINOGENESIS
- Long-term outcomes of aromatase inhibition for breast cancer
- (2008) Masakazu Toi LANCET ONCOLOGY
- 27-Hydroxycholesterol Is an Endogenous Selective Estrogen Receptor Modulator
- (2007) Carolyn D. DuSell et al. MOLECULAR ENDOCRINOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started